
Proteins held together by several disulfide bonds are among the hardest to make in a bacterium. The reducing environment of the bacterial cytoplasm discourages the correct pairing of cysteine residues, so the nascent chain tends to misfold, aggregate into inclusion bodies, and yield little or no soluble, active product. Solubilizing those aggregates and refolding them afterwards is possible, but it is slow and frequently returns protein that has lost activity. A dedicated disulfide-rich expression service tackles the problem upstream, by choosing a host and a folding route that let the bonds form as the protein is made.
The service is built for targets such as protease inhibitors, toxin-like domains, growth-factor fragments, receptor ectodomains, and cysteine-knot peptides — cases where a conventional bacterial expression run usually ends in an insoluble pellet.
The strategy is chosen from the sequence and the number and pattern of disulfide bonds, and several routes can be combined within one project.
A project can start from the gene sequence or the amino-acid sequence of the target. If an expression construct has already been prepared, its vector details, tag arrangement, and any earlier expression results help us decide whether to reuse it or rebuild it. The intended downstream use also matters, because a protein destined for a binding assay has different purity and activity requirements from one intended for crystallization.
The sequence is reviewed for disulfide pattern, signal peptides, and rare codons, and a small panel of host and construct combinations is assembled. Test expressions are compared on soluble yield and on the correctness of the disulfide pairing, not simply on total protein produced. The best condition is scaled up, the product is purified and, where required, refolded, and the final material is checked for purity, identity, and activity before delivery. If the first panel does not give a soluble product, the route is changed rather than the same condition being repeated at larger scale.
Deliverables include the purified protein at the agreed quantity, together with a technical report covering the construct, the host and expression conditions, the purification and refolding steps, and the characterization data. Solubility, purity, and activity are reported explicitly, since a high yield of inactive protein is not a successful outcome for this class of target. Preparations that do not meet the agreed criteria are not released.